{"acute disseminated encephalomyelitis": 2.79, "adverse reaction": 3.17, "allodynia": 5.09, "areflexia": 2.66, "bedridden": 7.91, "bell's palsy": 5.62, "blister": 11.74, "burning sensation": 3.2, "cellulitis": 4.52, "coronavirus infection": 3.46, "deafness unilateral": 2.32, "demyelinating polyneuropathy": 5.81, "demyelination": 2.54, "diplegia": 2.09, "discomfort": 2.56, "disease prodromal stage": 210.95, "dysaesthesia": 2.55, "encephalitis": 3.14, "erysipelas": 2.06, "erythema": 3.58, "extensive swelling of vaccinated limb": 2.45, "extra dose administered": 4.23, "facial pain": 4.35, "facial paralysis": 2.59, "facial paresis": 2.32, "genital herpes": 3.87, "genital herpes zoster": 23.41, "genital rash": 5.36, "giant cell arteritis": 2.84, "groin pain": 2.33, "guillain-barre syndrome": 11.55, "herpes ophthalmic": 15.94, "herpes simplex": 9.29, "herpes virus infection": 7.64, "herpes zoster": 37.46, "herpes zoster cutaneous disseminated": 34.63, "herpes zoster disseminated": 9.56, "herpes zoster oticus": 28.53, "herpes zoster reactivation": 24.37, "hyperaesthesia": 9.27, "immobile": 4.96, "inappropriate schedule of product administration": 2.36, "incomplete course of vaccination": 78.43, "incorrect route of product administration": 4.23, "induration": 5.55, "influenza like illness": 2.17, "injected limb mobility decreased": 8.02, "injection site cellulitis": 5.38, "injection site discolouration": 4.21, "injection site discomfort": 2.31, "injection site erythema": 4.64, "injection site induration": 2.08, "injection site pain": 2.13, "injection site paraesthesia": 2.72, "injection site rash": 4.91, "injection site swelling": 3.09, "injection site vesicles": 13.24, "injection site warmth": 2.06, "lip blister": 6.69, "local reaction": 14.36, "loss of personal independence in daily activities": 3.6, "lyme disease": 2.64, "lymphangitis": 4.45, "mobility decreased": 4.24, "monoplegia": 3.03, "myelitis transverse": 3.29, "near death experience": 2.35, "nerve injury": 3.88, "neuralgia": 9.5, "neuralgic amyotrophy": 4.99, "neuritis": 4.99, "ophthalmic herpes simplex": 20.24, "ophthalmic herpes zoster": 36.11, "oral herpes": 9.33, "oral mucosal blistering": 3.41, "pain": 3.29, "pain in extremity": 2.77, "pain of skin": 6.95, "paralysis": 2.56, "peripheral swelling": 2.38, "peripheral vascular disorder": 3.42, "polymyalgia rheumatica": 4.79, "post herpetic neuralgia": 40.91, "product administered at inappropriate site": 4.54, "product administered to patient of inappropriate age": 16.71, "product supply issue": 7.51, "pruritus": 2.22, "pustule": 5.77, "radiculopathy": 3.19, "rash": 2.79, "rash erythematous": 2.01, "rash papular": 2.55, "rash pruritic": 2.47, "rash pustular": 5.2, "rash vesicular": 33.94, "scab": 5.24, "scar": 4.44, "skin lesion": 4.21, "skin warm": 6.61, "social problem": 2.71, "swelling": 2.75, "tenderness": 2.2, "trigeminal neuralgia": 4.17, "vaccination failure": 6.68, "vaccination site erythema": 2.7, "vaccination site induration": 2.04, "vaccination site inflammation": 4.8, "vaccination site joint swelling": 3.17, "vaccination site rash": 2.09, "vaccination site reaction": 2.09, "vaccination site swelling": 2.2, "vaccination site warmth": 3.16, "varicella zoster virus infection": 11.26, "walking aid user": 2.47}